tiprankstipranks
Epirus Biopharma (EPRSQ)
OTHER OTC:EPRSQ
US Market

Epirus Biopharma (EPRSQ) Stock Price & Analysis

20 Followers

EPRSQ Stock Chart & Stats

Day’s Range<$0.01 - <$0.01
52-Week Range― - ―
Previous Close$0.000001
Volume3.00
Average Volume (3M)N/A
Market Cap
$26.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

EPRSQ FAQ

What was Epirus Biopharma’s price range in the past 12 months?
Currently, no data Available
What is Epirus Biopharma’s market cap?
Currently, no data Available
When is Epirus Biopharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Epirus Biopharma’s earnings last quarter?
Currently, no data Available
Is Epirus Biopharma overvalued?
According to Wall Street analysts Epirus Biopharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Epirus Biopharma pay dividends?
    Epirus Biopharma does not currently pay dividends.
    What is Epirus Biopharma’s EPS estimate?
    Epirus Biopharma’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Epirus Biopharma have?
    Currently, no data Available
    What happened to Epirus Biopharma’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Epirus Biopharma?
    Currently, no hedge funds are holding shares in EPRSQ
    ---

    Epirus Biopharma Stock Smart Score

    10
    Unlock Smart Score
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Company Description

    Epirus Biopharma

    EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company, which focuses on building a biosimilar business. It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference product. The company was founded on November 26, 2008 and is headquartered in Boston, MA.
    ---
    Similar Stocks
    Company
    Price & Change
    Follow
    Emergent Biosolutions
    Inovio Pharmaceuticals
    Ardelyx
    TG Therapeutics
    Popular Stocks
    ---
    What's Included in PREMIUM?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis